CN101797269B - 一种调节女性阴道微生态的生理平衡液 - Google Patents
一种调节女性阴道微生态的生理平衡液 Download PDFInfo
- Publication number
- CN101797269B CN101797269B CN2010101327417A CN201010132741A CN101797269B CN 101797269 B CN101797269 B CN 101797269B CN 2010101327417 A CN2010101327417 A CN 2010101327417A CN 201010132741 A CN201010132741 A CN 201010132741A CN 101797269 B CN101797269 B CN 101797269B
- Authority
- CN
- China
- Prior art keywords
- vagina
- vaginas
- balance liquid
- microecology
- physiological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001215 vagina Anatomy 0.000 title claims abstract description 70
- 239000007788 liquid Substances 0.000 title claims abstract description 48
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 38
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 38
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 38
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims abstract description 24
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 24
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 21
- 239000008103 glucose Substances 0.000 claims abstract description 21
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 20
- 150000001746 carotenes Chemical class 0.000 claims abstract description 20
- 235000005473 carotenes Nutrition 0.000 claims abstract description 20
- 229940111630 tea tree oil Drugs 0.000 claims abstract description 20
- 239000010677 tea tree oil Substances 0.000 claims abstract description 20
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims abstract description 20
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 19
- 239000001110 calcium chloride Substances 0.000 claims abstract description 19
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 19
- 235000011148 calcium chloride Nutrition 0.000 claims abstract description 19
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 19
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 19
- 229940099596 manganese sulfate Drugs 0.000 claims abstract description 19
- 239000011702 manganese sulphate Substances 0.000 claims abstract description 19
- 235000007079 manganese sulphate Nutrition 0.000 claims abstract description 19
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims abstract description 19
- 239000001103 potassium chloride Substances 0.000 claims abstract description 19
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 19
- 239000011780 sodium chloride Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 244000068988 Glycine max Species 0.000 claims description 43
- 235000010469 Glycine max Nutrition 0.000 claims description 43
- 239000002671 adjuvant Substances 0.000 claims description 21
- 239000004615 ingredient Substances 0.000 claims description 19
- 230000001105 regulatory effect Effects 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 12
- 241000186660 Lactobacillus Species 0.000 abstract description 20
- 229940039696 lactobacillus Drugs 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 19
- 206010046914 Vaginal infection Diseases 0.000 abstract description 11
- 239000006210 lotion Substances 0.000 abstract description 10
- 201000008100 Vaginitis Diseases 0.000 abstract description 9
- 241000894006 Bacteria Species 0.000 abstract description 8
- 210000004877 mucosa Anatomy 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 244000052769 pathogen Species 0.000 abstract description 3
- 230000004962 physiological condition Effects 0.000 abstract description 3
- 239000006041 probiotic Substances 0.000 abstract description 3
- 235000018291 probiotics Nutrition 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 4
- 230000003749 cleanliness Effects 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 51
- 238000005406 washing Methods 0.000 description 19
- 235000002639 sodium chloride Nutrition 0.000 description 17
- 230000035479 physiological effects, processes and functions Effects 0.000 description 15
- 239000000470 constituent Substances 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 244000052616 bacterial pathogen Species 0.000 description 9
- 229940011871 estrogen Drugs 0.000 description 7
- 239000000262 estrogen Substances 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 239000000820 nonprescription drug Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 239000012467 final product Substances 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 210000004392 genitalia Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000036649 Dysbacteriosis Diseases 0.000 description 2
- 208000027244 Dysbiosis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 208000006374 Uterine Cervicitis Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000001364 causal effect Effects 0.000 description 2
- 206010008323 cervicitis Diseases 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000007140 dysbiosis Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 239000008921 jie er yin Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000032159 Vaginal inflammation Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940126587 biotherapeutics Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012627 chemopreventive agent Substances 0.000 description 1
- 229940124443 chemopreventive agent Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 210000004061 pubic symphysis Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
效应 | F | P |
治疗组间 | 0.697 | 0.407 |
中心间 | 0.869 | 0.354 |
治疗前后 | 33.360 | <0.001 |
治疗与时间交互作用 | 8.567 | 0.005 |
中心与时间交互作用 | 4.081 | 0.047 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101327417A CN101797269B (zh) | 2010-03-23 | 2010-03-23 | 一种调节女性阴道微生态的生理平衡液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101327417A CN101797269B (zh) | 2010-03-23 | 2010-03-23 | 一种调节女性阴道微生态的生理平衡液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101797269A CN101797269A (zh) | 2010-08-11 |
CN101797269B true CN101797269B (zh) | 2012-01-04 |
Family
ID=42593209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101327417A Active CN101797269B (zh) | 2010-03-23 | 2010-03-23 | 一种调节女性阴道微生态的生理平衡液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101797269B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101133723B1 (ko) * | 2009-10-19 | 2012-04-09 | 최원석 | 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도 |
CN106176916A (zh) * | 2016-08-13 | 2016-12-07 | 广州婕熹卡生物科技有限公司 | 一种女性阴道平衡护理液 |
CN107049934A (zh) * | 2017-03-10 | 2017-08-18 | 山西纳安生物科技有限公司 | 一种调节女性阴道微生态的妇科阴道洗液及其制备方法 |
CN107028978A (zh) * | 2017-04-11 | 2017-08-11 | 山西纳安生物科技有限公司 | 一种妇女阴道凝胶剂及其制备方法 |
CN108354973B (zh) * | 2018-05-23 | 2021-05-07 | 山东名德医疗科技有限公司 | 抑菌护理液 |
AU2019397458A1 (en) * | 2018-12-11 | 2021-06-17 | Glyciome, Llc | Topical, isotonic compositions for genital use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7179481B2 (en) * | 2002-09-19 | 2007-02-20 | Kimberly-Clark Worldwide, Inc. | Vaginal health products |
BRPI0809330B8 (pt) * | 2007-03-30 | 2021-05-25 | Laccure Ab | uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica |
CN101249061A (zh) * | 2008-03-17 | 2008-08-27 | 孙和平 | 一种用于解毒消炎的霜剂及其制备方法 |
CN101543514A (zh) * | 2009-05-06 | 2009-09-30 | 大连润生堂生物科技工程有限公司 | 预防或治疗阴道炎的复合乳酸菌洁阴护理液及工艺 |
-
2010
- 2010-03-23 CN CN2010101327417A patent/CN101797269B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101797269A (zh) | 2010-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101797304B (zh) | 一种调节女性阴道微生态的凝胶 | |
CN101797269B (zh) | 一种调节女性阴道微生态的生理平衡液 | |
CN106727849A (zh) | 一种妇科凝胶 | |
CN103041367A (zh) | 一种防治阴道炎的中药复方制剂及其制备方法 | |
CN103157095B (zh) | 芸豆植物凝集素在制备人用药物中的应用及其药物组合物 | |
CN113081928A (zh) | 一种植物抑菌凝胶及其制备方法和应用 | |
CN109985069A (zh) | 益生菌组合物及其用途 | |
CN110384725B (zh) | 一种用于调整口腔菌群的中药组合及其活性提取物的制备 | |
CN103191408B (zh) | 一种治疗阴道炎的药物组合物、凝胶剂及其用途 | |
CN109316550A (zh) | 一种清洁抑菌用护理剂 | |
CN106377602A (zh) | 一种铁皮石斛复合消毒粉及制备方法和使用方法 | |
CN109602813A (zh) | 一种抑菌凝胶剂及其制备方法 | |
KR101453834B1 (ko) | 생약재를 이용한 세정제 조성물 제조 방법 및 이를 이용한 세정제 조성물 | |
CN102716408B (zh) | 草果油在制备治疗阴道炎的药物中的用途 | |
CN101766638B (zh) | 替代雌激素治疗老年性阴道炎局部用的药物 | |
CN103520262A (zh) | 一种脂溶性妇科凝胶 | |
CN103599437B (zh) | 一种治疗阴道炎的中药药液 | |
CN111184832A (zh) | 一种具有缩阴润滑、养巢护巢功能的植物益生菌组合物及其制备方法 | |
CN108785383A (zh) | 一种抗菌妇科外用药物组合物及其制备方法与应用 | |
CN105326954A (zh) | 一种治疗睑缘炎的中药组合物及其制备方法 | |
CN100352449C (zh) | 一种治疗脚癣和体癣的药物组合物及其制备方法 | |
CN111632073A (zh) | 一种抗菌消炎的女性私密益生菌组合物及其制备 | |
CN1431012A (zh) | 治疗妇科炎症的外用中药及使用方法 | |
CN101530403A (zh) | 用于治疗或预防妇女阴道炎、宫颈糜烂的木糖醇组合物 | |
CN106580981B (zh) | 一种治疗妇科炎症的药物组合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TAIYUAN JINBO BIOMEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: YANG XIA Effective date: 20141231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 030001 TAIYUAN, SHAANXI PROVINCE TO: 030032 TAIYUAN, SHAANXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141231 Address after: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Patentee after: Taiyuan Jinbo Bio-Pharmaceutical Co.,Ltd. Address before: 030001 No. 59 Kangle West Street, Ankang District, 3, Shanxi, Taiyuan Patentee before: Yang Xia |
|
C56 | Change in the name or address of the patentee |
Owner name: SHANXI JINBO BIOLOGICAL PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: TAIYUAN JINBO BIOMEDICAL TECHNOLOGY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Patentee after: Shanxi Jin Bo Biomedics Inc. Address before: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Patentee before: Taiyuan Jinbo Bio-Pharmaceutical Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |
Address after: 030032 No.18, Jinbo street, Tanghuai Park, Taiyuan comprehensive reform demonstration zone, Taiyuan City, Shanxi Province Patentee after: SHANXI JINBO BIOMEDICAL Co.,Ltd. Address before: 030032 Shanxi city of Taiyuan province by the economic and Technological Development Zone No. 18 North Street Patentee before: SHANXI JINBO BIOMEDICAL Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |